Skip to main content
. 2019 Jul 4;19:150. doi: 10.1186/s12866-019-1522-7

Table 1.

Antibiogram of the OprD-deficient P. aeruginosa efflux mutant isogenic strain set showing MICs (μg/mL)a

Antibacterial agent MB6476b MB6477c MIC differenced MB6477c ΔmexR (overexpresses MexAB) MB6477c ΔnfxB (overexpresses MexCD) MB6477c ΔmexL (overexpresses MexJK) MB6477c ΔmexZ (overexpresses MexXY)
Imipenem 16 16 1-fold 16 4 16 16
IMI/RELe 1 1 1-fold 1 0.25 1 1
Ceftazidimef 1 1 1-fold ND ND ND ND
Aztreonamg 0.5 4 8-fold ND ND ND ND
Meropenemf 1 1 to 2 1- to 2-fold 16 4 2 2
Chloramphenicolg 2 > 256 > 128-fold ND ND ND ND
Levofloxacing 0.0078 4 512-fold 8 4 4 4

IMI/REL imipenem/relebactam, MIC minimum inhibitory concentration, ND not determined, OprD outer membrane porin D, RND resistance-nodulation-cell division

aMIC values were determined by 2-fold serial broth microdilution

bMB6476 nfxC, Δ [MexAB-OprM] Δ [MexCD-OprJ] Δ [MexXY] Δ [MexJK-OprLL] Δ [MexHI-OpmD] Δ [OpmH]), spontaneous OprD deletion

cMB6477 nfxC, wild-type for other efflux pumps, spontaneous OprD deletion

dRatio between the MIC for MB6477 divided by the MIC for MB6476, for the respective antibacterial agent

eImipenem combined with 4 μg/mL of relebactam

fControl antibacterial agent known to be an RND efflux pump substrate, with susceptibility known to be adversely affected by efflux pump overexpression [49, 50]

gControl antibacterial agent known to be an RND efflux pump substrate, with susceptibility known to be adversely affected even in wild-type P. aeruginosa with baseline efflux pump expression [49, 50]